Literature DB >> 8832457

Molecular biology of pediatric gliomas.

C Raffel1.   

Abstract

The genes involved in the genesis and progression of adult astrocytic tumors have been an area of considerable investigation. The tumor suppressor gene, p53, has been implicated, as has the epidermal growth factor receptor gene. Additional currently unidentified genes lie on chromosomes 10 and 19. Interestingly, work on pediatric astrocytomas suggests that the genes involved are different. p53 is rarely mutated in pediatric tumors, the epidermal growth factor receptor gene is rarely amplified or mutated, and chromosome 10 deletions are rare. The only pediatric tumor that seems to mimic the findings in adult tumors is brainstem glioma, perhaps explaining the uniformly grim prognosis in this type of tumor. In the pilocytic astrocytoma of childhood, mutations in the neurofibromatosis type I gene have been implicated in tumor development. In this review, the oncogenesis of pediatric gliomas is discussed and compared and contrasted to what is known about tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832457     DOI: 10.1007/bf00250194

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  90 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

2.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

3.  Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma.

Authors:  A K Metzger; V C Sheffield; G Duyk; L Daneshvar; M S Edwards; P H Cogen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  Chromosomal composition of a series of 22 human low-grade gliomas.

Authors:  J A Rey; M J Bello; J M de Campos; M E Kusak; S Moreno
Journal:  Cancer Genet Cytogenet       Date:  1987-12

7.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 8.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

9.  Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.

Authors:  M R Johnson; J E DeClue; S Felzmann; W C Vass; G Xu; R White; D R Lowy
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.

Authors:  A von Deimling; B Bender; R Jahnke; A Waha; J Kraus; S Albrecht; R Wellenreuther; F Fassbender; J Nagel; A G Menon
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

View more
  2 in total

Review 1.  Bone marrow metastasis in astrocytic gliomata.

Authors:  E Hsu; D Keene; E Ventureyra; M A Matzinger; C Jimenez; H S Wang; L Grimard
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

2.  Management of posterior fossa gliomas in children.

Authors:  K Sridhar; R Sridhar; G Venkatprasanna
Journal:  J Pediatr Neurosci       Date:  2011-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.